BioMarin Pharmaceutical
BMRN
#1872
Rank
S$13.47 B
Marketcap
S$70.08
Share price
-1.94%
Change (1 day)
-26.90%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2025 (TTM): S$0.62 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are S$3.22 Billion. a decrease over its 2024 earnings that were of S$0.69 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2025

Annual earnings

Year Earnings Change
2025 S$0.62 B-10.94%
2024 S$0.69 B187.31%
2023 S$0.24 B26.07%
2022 S$0.19 B-298.51%
2021 -S$96.95 Million78.04%
2020 -S$54.46 Million-55.36%
2019 -S$0.13 Billion-33.56%
2018 -S$0.19 Billion297.78%
2017 -S$46.16 Million-95.68%
2016 -S$1.07 Billion437.12%
2015 -S$0.2 Billion23.91%
2014 -S$0.17 Billion-29.25%
2013 -S$0.23 Billion49.23%
2012 -S$0.16 Billion171.11%
2011 -S$56.14 Million103.01%
2010 -S$27.66 Million-3903.54%
2009 S$0.72 M-98.31%
2008 S$43 M-189.7%
2007 -S$47.95 Million51.02%
2006 -S$31.75 Million-61.58%
2005 -S$82.63 Million-56.59%
2004 -S$0.2 Billion95.13%
2003 -S$97.54 Million12.09%
2002 -S$87.01 Million73.19%
2001 -S$50.25 Million18.32%
2000 -S$42.47 Million19.65%
1999 -S$35.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sanofi
SNY
S$9.90 B 1,495.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-S$0.66 Billion-205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-S$0.15 Billion-122.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-S$35.31 Million-105.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$0.24 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
S$0.36 B-41.24%๐Ÿ‡บ๐Ÿ‡ธ USA